Navigation Links
FDA approves Phase II of stem cell trial for ALS led by U-M's Dr. Eva Feldman
Date:4/17/2013

fred Taubman Medical Research Institute. The neurosurgeon for the trial is Parag Patil, M.D, Ph.D.

The approach uses injections of stem cells delivered during an operation performed by a neurosurgeon. The first phase of the trial involved 15 patients; specific plans for Phase II are still being made but information will be available at neuralstem.com.

If the U-M site team receives IRB approval to recruit local participants, more information will be available at uofmhealth.org. The study at U-M will be funded by the ALS Association, the National Institutes of Health and Neuralstem.


'/>"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Page: 1 2

Related biology news :

1. King Richard III search in new phase after discovery has potential to rewrite history
2. National Geographic unveils new phase of genographic project
3. F1000Research, the first Open Science publisher, launches following a successful beta testing phase
4. In beef production, cow-calf phase contributes most greenhouse gases
5. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
6. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
7. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
8. New clinical trial explores novel noninvasive colon cancer screening test
9. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
10. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
11. Trial launched into curry chemicals cancer-fighting properties
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications ... a global provider of Software Defined Network Architecture (ET ... announced total revenue of approximately $20.4 million for the ... restated $19.5 million for the year ended December 31, ... 2014, the Company had completed its multi-year transition away ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , a ... of the Post-Surgical Pain Management TRACKER, part of the ... usage trends in the medical device and therapeutics markets. ... data including treatment volumes, market share, and adoption rates ... associated with joint surgery. The Post-Surgical Pain ...
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... will join researchers from around the world to celebrate ... treaty designed to reduce the hole in Earth,s protective ... the meeting from Sept. 23-26 in Athens, Greece. NASA ... the recovery of the ozone layer. "The Montreal ...
... (UWM) are working with local company PhysioGenix to investigate ... researching diseases like depression, anxiety, schizophrenia and ADHD. ... by researchers at the Medical College of Wisconsin (MCW) ... diseases. Called consomic rats, they were produced by replacing ...
... Fred Dryer has a lofty goal: end the nation,s ... potentially major benefits for energy security and the environment ... knowledge of jet fuels while developing practical, innovative energy ... sources feasible, they need to be compatible with petroleum ...
Cached Biology News:NASA keeps eye on ozone layer amid Montreal Protocol's success 2NASA keeps eye on ozone layer amid Montreal Protocol's success 3A new kind of rat model 2Green skies: Engineer's work may reduce jet travel's role in global warming 2Green skies: Engineer's work may reduce jet travel's role in global warming 3Green skies: Engineer's work may reduce jet travel's role in global warming 4
(Date:3/31/2015)... JUNCTION, N.J., March 31, 2015 CytoSorbents ... company using blood purification to treat critically-ill and ... an operational summary and reports financial results for ... 2014 CytoSorb® product revenues were a ... compared to 2013 CytoSorb® revenues of $0.8M Highlights ...
(Date:3/31/2015)... 31, 2015  Biotest Pharmaceuticals Corporation (BPC), a leading ... the addition of its newest plasma collection center located ... Conway, Arkansas . The over 16,000 square foot ... March 26 th 2015 and brings the total ... "This facility represents another milestone in our ...
(Date:3/31/2015)... VANCOUVER , March 31, 2015  /PRNewswire/ ... announced today that it has filed with the Food ... New Drug ("IND") application related to the Company,s proposed ... of the IND application is required in order for ... US.  The IND application is a ...
(Date:3/31/2015)... Eastern Kentucky University is ranked among ... criminal justice degree programs by Nonprofitcollegesonline.com. , “We ... and high quality educational opportunities,” Editor Liz Robertson ... are confident that students will find both at ... site’s first “Students before Profits” list, and EKU ...
Breaking Biology Technology:CytoSorbents Reports Record 2014 Revenue 2CytoSorbents Reports Record 2014 Revenue 3CytoSorbents Reports Record 2014 Revenue 4CytoSorbents Reports Record 2014 Revenue 5CytoSorbents Reports Record 2014 Revenue 6CytoSorbents Reports Record 2014 Revenue 7CytoSorbents Reports Record 2014 Revenue 8CytoSorbents Reports Record 2014 Revenue 9CytoSorbents Reports Record 2014 Revenue 10CytoSorbents Reports Record 2014 Revenue 11Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Conway, Arkansas 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 3ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 4EKU Ranked in Top 50 Among Online Criminal Justice Degrees 2
... LAUDERDALE, Fla., Jan. 16 OmniComm Systems,Inc. (OTC Bulletin ... for clinical trials, today announced record breaking results,for 2008 ... A,record jump of 80% in contracts over 2007 clearly ... Marketplace. , "OmniComm has worked ...
... VARI) today announced preliminary results for the first quarter ... , First quarter sales should ... (adjusted) diluted earnings per share should be between $0.50 ... On a GAAP,basis, diluted earnings per share should be ...
... difficult,financial times and flat federal funding of biomedical research, ... at modest cost --,can yield dramatic results for patients ... Cancer Institute (NCI) in a commentary published today by ... ) , In the ...
Cached Biology Technology:OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 2008 2OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 2008 3Varian, Inc. Announces First Quarter 2009 Preliminary Results 2Varian, Inc. Announces First Quarter 2009 Preliminary Results 3Varian, Inc. Announces First Quarter 2009 Preliminary Results 4Varian, Inc. Announces First Quarter 2009 Preliminary Results 5Varian, Inc. Announces First Quarter 2009 Preliminary Results 6National Cancer Institute: Battling Cancer and a Recession 2National Cancer Institute: Battling Cancer and a Recession 3
Component of GELase™ Agarose Gel-Digesting Preparation. 1 ml of 50X Buffer is sufficient for replacing the buffer in at least 5 g of gel....
...
Form: Concentrated Applications: ELISA...
Form: Ready to use Applications: ELISA...
Biology Products: